$3.73
0.0752.05%
Last update: Nov 10, 2:35 PM
Immuneering Corp
IMRXNASDAQ
Immuneering (IMRX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.30 | $-0.27 | $-0.26 | $-0.31 |
| Actual | $-0.37 | $-0.27 | $-0.21 | $-0.18 |
| Surprise | -23.3% | 0.00% | +19.2% | +41.9% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | — | $0 | $0 | — |
| Surprise | — | — | — | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.40 | $-0.35 | $-0.44 | $-0.46 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 29, 2026 | $-0.37 | $-0.30 | -23.3 % |
| Q2 | Aug 5, 2026 | $-0.27 | $-0.27 | 0.00 % |
| Q1 | May 15, 2026 | $-0.21 | $-0.26 | 19.2 % |
| Q4 | Mar 6, 2026 | $-0.18 | $-0.31 | 41.9 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | May 4, 2023 | $0 | $10.00K | -100.0 % |
| Q4 | Mar 6, 2023 | $456.00 | $60.00K | -99.2 % |
| Q3 | Nov 10, 2022 | $38.38K | $150.00K | -74.4 % |
| Q2 | Aug 10, 2022 | $94.42K | $180.00K | -47.5 % |
